Repository logo


Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturation

dc.contributor.authorVrahnas, Cen_AU
dc.contributor.authorPearson, TAen_AU
dc.contributor.authorBrunt, ARen_AU
dc.contributor.authorForwood, MRen_AU
dc.contributor.authorBambery, KRen_AU
dc.contributor.authorTobin, MJen_AU
dc.contributor.authorMartin, TJen_AU
dc.contributor.authorSims, NAen_AU
dc.date.accessioned2026-09-11T04:54:15Zen_AU
dc.date.issued2016-12en_AU
dc.date.statistics2026-07-29en_AU
dc.description.abstractIntermittent administration of parathyroid hormone (PTH) is used to stimulate bone formation in patients with osteoporosis. A reduction in the degree of matrix mineralisation has been reported during treatment, which may reflect either production of undermineralised matrix or a greater proportion of new matrix within the bone samples assessed. To explore these alternatives, high resolution synchrotron-based Fourier Transform Infrared Microspectroscopy (sFTIRM) coupled with calcein labelling was used in a region of non-remodelling cortical bone to determine bone composition during anabolic PTH treatment compared with region-matched samples from controls. 8 week old male C57BL/6 mice were treated with vehicle or 50 μg/kg PTH, 5 times/week for 4 weeks (n = 7–9/group). Histomorphometry confirmed greater trabecular and periosteal bone formation and 3-point bending tests confirmed greater femoral strength in PTH-treated mice. Dual calcein labels were used to match bone regions by time-since-mineralisation (bone age) and composition was measured by sFTIRM in six 15 μm2 regions at increasing depth perpendicular to the most immature bone on the medial periosteal edge; this allowed in situ measurement of progressive changes in bone matrix during its maturation. The sFTIRM method was validated in vehicle-treated bones where the expected progressive increases in mineral:matrix ratio and collagen crosslink type ratio were detected with increasing bone maturity. We also observed a gradual increase in carbonate content that strongly correlated with an increase in longitudinal stretch of the collagen triple helix (amide I:amide II ratio). PTH treatment did not alter the progressive changes in any of these parameters from the periosteal edge through to the more mature bone. These data provide new information about how the bone matrix matures in situ and confirm that bone deposited during PTH treatment undergoes normal collagen maturation and normal mineral accrual. © 2016 Elsevier Inc. All rights reserved.en_AU
dc.description.sponsorshipThe authors gratefully acknowledge Mrs. Ingrid Poulton for expert technical assistance, Dr. Michael Gorman for advice on collagen structure, Dr. Eleftherios P Paschalis for help with spectral curvefitting, Drs Adele Boskey and Ljudmila Spevak for initial FTIR advice. This work was supported by National Health and Medical Research Council (Australia) Project Grant 1042129. N.A.S. is supported by a National Health and Medical Research Council (Australia) Senior Research Fellowship. St. Vincent's Institute is supported by the Victorian Government's Operational Infrastructure Support Programme. sFTIRM data collection was undertaken on the infrared microspectroscopy (IRM) beamline at the Australian Synchrotron, Victoria, Australia.en_AU
dc.format.mediumPrint-Electronicen_AU
dc.identifier.citationVrahnas, C., Pearson, T. A., Brunt, A. R., Forwood, M. R., Bambery, K. R., Tobin, M. J., Martin, T. J., & Sims, N. A. (2016). Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturation. Bone, 93, 146–154. doi:10.1016/j.bone.2016.09.022en_AU
dc.identifier.issn8756-3282en_AU
dc.identifier.issn1873-2763en_AU
dc.identifier.journaltitleBoneen_AU
dc.identifier.pagination146-154en_AU
dc.identifier.urihttps://doi.org/10.1016/j.bone.2016.09.022en_AU
dc.identifier.urihttps://apo.ansto.gov.au/handle/10238/17370en_AU
dc.identifier.volume93en_AU
dc.languageEnglishen_AU
dc.language.isoenen_AU
dc.publisherElsevieren_AU
dc.subjectParathyroid glandsen_AU
dc.subjectHormonesen_AU
dc.subjectBone cellsen_AU
dc.subjectMineralsen_AU
dc.subjectSynchrotronsen_AU
dc.subjectFluorescenceen_AU
dc.subjectThyroid hormonesen_AU
dc.subjectMineralizationen_AU
dc.subjectCollagenen_AU
dc.titleAnabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturationen_AU
dc.typeJournal Articleen_AU
dcterms.dateAccepted2016-09-25en_AU

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.66 KB
Format:
Plain Text
Description:

Collections